ARTICLE | Company News
Collegium, Cypress deal
June 12, 2006 7:00 AM UTC
Collegium received an undisclosed milestone payment from CYPB under a 2002 deal to develop new formulations and analogs of CYPB's milnacipran norepinephrine serotonin reuptake inhibitor (see BioCentur...